US Broker Ratings

Inventiva S.A. (IVA) Stock Analysis: Riding the Wave of a 149.74% Potential Upside

Inventiva S.A. (IVA), listed as an American Depositary Share, has captured the attention of savvy investors in the biotechnology sector with a tantalizing potential upside of 149.74%. As a clinical-stage..

Ginkgo Bioworks Holdings (DNA) Stock Analysis: Navigating the Biotech Landscape with a 13.77% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, stands out for its innovative approach to cell programming and biosecurity. Despite facing financial challenges, the company’s..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 823.91% Upside

Cel-Sci Corporation (NASDAQ: CVM) stands out in the biotechnology sector with an eye-catching potential upside of 823.91%, according to recent analyst ratings. This clinical-stage biotech firm, headquartered in Vienna, Virginia,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Unveiling a 28% Potential Upside

AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, is navigating a challenging yet opportunity-laden landscape. Specializing in medical care facilities, AMN provides crucial technology-enabled workforce solutions..

Butterfly Network, Inc. (BFLY) Stock Analysis: 66% Potential Upside Sparks Investor Interest

Butterfly Network, Inc. (NYSE: BFLY), a prominent player in the healthcare sector, is shaking up the medical devices industry with its innovative ultrasound imaging solutions. Known for its cutting-edge technology,..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: Exploring a 50% Upside Potential in Neurodegenerative Drug Development

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage pharmaceutical company, is drawing attention from investors due to its significant potential upside of 50.04% according to analyst ratings. Operating within the healthcare..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring 130% Potential Upside in the Biotech Sector

Gyre Therapeutics, Inc. (GYRE), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 130.18%. Headquartered in San Diego, California, Gyre..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a 159.97% Potential Upside

For investors with an eye on the biotechnology sector, Cullinan Therapeutics, Inc. (CGEM) presents a compelling opportunity. With a market capitalization of $690.6 million and a strategic focus on developing..

InMode Ltd. (INMD) Stock Analysis: Exploring Growth Potential and a 17.48% Upside in the Medical Device Sector

InMode Ltd. (NASDAQ: INMD) is capturing attention in the healthcare sector with its innovative approach to medical devices, specifically in the realm of minimally invasive aesthetic procedures. Headquartered in Yokne’am,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Growth in Healthcare

Avanos Medical, Inc. (NYSE: AVNS), a notable player in the medical devices sector, presents a compelling case for investors seeking opportunities within the healthcare industry. Headquartered in Alpharetta, Georgia, Avanos..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Exploring an 84% Potential Upside in the Biotech Sector

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. With a market cap of $1.84..

MeiraGTx Holdings plc (MGTX): Investor Outlook with a Potential 263% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a biotechnology company at the forefront of genetic medicine, is garnering significant attention from investors due to its innovative pipeline and impressive potential upside. Specializing..

Zymeworks Inc. (ZYME) Stock Analysis: A Biotech Gem with 57% Potential Upside

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is at the forefront of developing biotherapeutics for cancer and autoimmune diseases. With a notable market cap of $1.76 billion, this U.S.-based..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 4.24% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a range of medical care facilities across the United States. With a market capitalization of $482.01..

Auna SA (AUNA) Stock Analysis: Exploring a Potential 46% Upside in Healthcare

Auna SA (AUNA), a healthcare service provider operating hospitals and clinics in Mexico, Peru, and Colombia, presents a compelling opportunity for investors seeking exposure to the healthcare sector. Based in..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a Potential -40% Downside Amid Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV) presents a compelling narrative for investors in the healthcare sector, with its focus on providing comprehensive care services to seniors. Headquartered in Denver, Colorado, InnovAge..

REGENXBIO Inc. (RGNX) Stock Analysis: A 240.77% Potential Upside Amidst Innovative Gene Therapy Advances

Investors with a keen eye on the biotechnology sector may find REGENXBIO Inc. (NASDAQ: RGNX) an intriguing prospect. With a market capitalization of $422.7 million and a focus on pioneering..

Valneva SE (VALN): Investor Outlook Highlights Potential 26.87% Upside Amid Biotech Challenges

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in vaccines for infectious diseases, presents an intriguing opportunity for investors with a potential upside of 26.87%, according to recent analyst..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges with a Strategic Outlook

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare staffing industry, finds itself at a crossroads amid a challenging financial landscape. With a market capitalization of $260.44..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 46.95% Potential Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly within the medical devices industry, offers a compelling investment proposition characterized by a notable potential upside of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds